Wedmont Private Capital’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $299K | Sell |
1,324
-752
| -36% | -$170K | 0.01% | 572 |
|
2025
Q1 | $437K | Buy |
2,076
+433
| +26% | +$91.2K | 0.02% | 419 |
|
2024
Q4 | $545K | Sell |
1,643
-1
| -0.1% | -$332 | 0.03% | 353 |
|
2024
Q3 | $477K | Sell |
1,644
-100
| -6% | -$29K | 0.03% | 365 |
|
2024
Q2 | $563K | Sell |
1,744
-223
| -11% | -$72K | 0.04% | 313 |
|
2024
Q1 | $772K | Buy |
1,967
+87
| +5% | +$34.1K | 0.06% | 231 |
|
2023
Q4 | $661K | Sell |
1,880
-79
| -4% | -$27.8K | 0.05% | 239 |
|
2023
Q3 | $750K | Buy |
1,959
+96
| +5% | +$36.8K | 0.08% | 173 |
|
2023
Q2 | $717K | Buy |
1,863
+15
| +0.8% | +$5.78K | 0.08% | 177 |
|
2023
Q1 | $646K | Buy |
1,848
+118
| +7% | +$41.3K | 0.09% | 175 |
|
2022
Q4 | $402K | Buy |
1,730
+884
| +104% | +$206K | 0.06% | 258 |
|
2022
Q3 | $208K | Sell |
846
-237
| -22% | -$58.3K | 0.04% | 352 |
|
2022
Q2 | $327K | Sell |
1,083
-188
| -15% | -$56.8K | 0.07% | 217 |
|
2022
Q1 | $520K | Buy |
1,271
+650
| +105% | +$266K | 0.12% | 139 |
|
2021
Q4 | $236K | Buy |
+621
| New | +$236K | 0.07% | 208 |
|